Ofatumumab, a fully human anti-CD20 monoclonal antibody, is a disease-modifying therapy (DMT) approved for the treatment of ...

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and ...

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populatio ...

projected on-label aflibercept 2 mg Q8W, 70% required 0-1 supplemental ... years of follow-up (best available data as of November 20, 2024) Provided Phase 3 4FRONT program overview and update ...

Each gummy contains 10 mg of muscimol, 20 mg of CBD, and 10 mg of hemp-derived delta-9 THC ... and some products could contain potentially harmful research chemicals such as 4-AcO-DMT. It’s hard to ...

You might have seen Cialis® — the erectile dysfunction (ED) drug — available in doses ranging from 2.5 mg to 20 mg. Surely, ...

A more recent study published in 2023 in the same journal compared the experiences of a person who had both a near-death experience and a trip on 5-MeO-DMT, a powerful psychedelic cousin of DMT ...

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

Enveric Biosciences, Inc. ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, ...